Possible role of rivoglitazone thiazolidine class of drug as dual-target therapeutic agent for bacterial infections: An in silico study

Clicks: 305
ID: 78147
2019
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
yele2019possiblemedical Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Yele, V.
Journal medical hypotheses
Year 2019
DOI
10.1016/j.mehy.2019.109305
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.